Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease

Clinical trial NCT02393612 · COMPLETED

Trial details

NCT number: NCT02393612
Sponsor: Alvogen Korea
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2012-10-01
Primary completion: 2014-04-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.